Institute of Molecular Physiology, Molecular Cell Biology, Johannes Gutenberg University Mainz, Mainz, Germany.
Basic Clin Pharmacol Toxicol. 2023 Oct;133(4):301-312. doi: 10.1111/bcpt.13860. Epub 2023 Mar 30.
VLGR1/ADGRV1 (very large G protein-coupled receptor-1) is the largest adhesion G protein-coupled receptor (aGPCR). Mutations in VLGR1/ADGRV1 are associated with human Usher syndrome, the most common form of deaf-blindness, and also with epilepsy in humans and mice. VLGR1 is expressed almost ubiquitously but is mainly found in the CNS and in the sensory cells of the eye and inner ear. Little is known about the pathogenesis of the diseases related to VLGR1. We previously identified VLGR1 as a vital component of focal adhesions (FAs) serving as a metabotropic mechanoreceptor controls cell spreading and migration. FAs are highly dynamic and turnover in response to internal and external signals. Here, we aimed to elucidate how VLGR1 participates in FA turnover. Nocodazole washouts and live cell imaging of paxillin-DsRed2 consistently showed that FA disassembly was not altered, but de novo assembly of FA was significantly delayed in Vlgr1-deficient astrocytes, indicating that VLGR1 is enrolled in FA assembly. In FRAP experiments, recovery rates were significantly reduced in Vlgr1-deficient FAs, indicating reduced turnover kinetics in VLGR1-deficient FAs. We showed that VLGR1 regulates cell migration by controlling the FA turnover during their assembly and expect novel insights into pathomechanisms related to pathogenic dysfunctions of VLGR1.
VLGR1/ADGRV1(超大 G 蛋白偶联受体-1)是最大的黏附 G 蛋白偶联受体(aGPCR)。VLGR1/ADGRV1 的突变与人类 Usher 综合征有关,这是最常见的聋盲形式,也与人类和小鼠的癫痫有关。VLGR1 几乎普遍表达,但主要存在于中枢神经系统和眼睛和内耳的感觉细胞中。关于与 VLGR1 相关的疾病的发病机制知之甚少。我们之前将 VLGR1 鉴定为作为代谢机械感受器的粘着斑(FA)的重要组成部分,控制细胞铺展和迁移。FA 高度动态,并且响应内部和外部信号而发生转化。在这里,我们旨在阐明 VLGR1 如何参与 FA 转化。紫杉醇洗涤和质膜联蛋白-DsRed2 的活细胞成像一致表明 FA 解聚没有改变,但在 Vlgr1 缺陷型星形胶质细胞中 FA 的从头组装明显延迟,表明 VLGR1 参与 FA 组装。在 FRAP 实验中,在 VLGR1 缺陷型 FA 中,恢复率显着降低,表明 VLGR1 缺陷型 FA 中的周转率动力学降低。我们表明 VLGR1 通过控制 FA 在组装过程中的周转率来调节细胞迁移,并且期望对与 VLGR1 致病功能障碍相关的病理机制有新的认识。